Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
批准号:
10371249
负责人:
BRYAN R. CULLEN
金额:
$32.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-15 至 2023-03-31
关键词:
AdenosineAffectApplications GrantsAttentionCD4 Positive T LymphocytesCellsDepositionElectroconvulsive TherapyEnvironmental Risk FactorExposure toGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomeGoalsGrowth and Development functionHIV GenomeHIV-1Heat-Shock ResponseHigh Pressure Liquid ChromatographyImmune responseIndividualInfectionInfluenza A virusKnock-outLightLocationMapsMeasuresMessenger RNAModificationMorphineMurine leukemia virusMutagenesisMutateMyeloid CellsNicotineNuclearNucleotidesPathogenicityPatternPharmaceutical PreparationsPhenotypePoly(A)+ RNAPositioning AttributePost-Transcriptional RegulationProcessProteinsProvirusesPseudouridinePublishingRNARNA InterferenceRNA StabilityRegulationReportingResearchRoleSilent MutationSiteStressTechniquesTestingTranscriptUntranslated RNAUridineViralViral GenesViral PathogenesisVirionVirusVirus ReplicationWorkbasecell growthdesigndrug of abuseenvironmental stressorepitranscriptomicsgenomic RNAin vivointerestmRNA ExportmRNA Expressionmethyl groupmutantoverexpressionpressuretandem mass spectrometryviral RNAviral genomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
While the epitranscriptomic regulation of viral RNA function has begun to attract considerable attention,
this work has so far focused entirely on a single epitranscriptomic modification, i.e., the addition of a methyl
group to the N6 position of adenosine (m6A). This focus is understandable, given that m6A is the most common
epitranscriptomic modification of cellular mRNAs and it has been known for ~40 years that viral transcripts also
contain high levels of m6A. Moreover, we and others have reported that m6A regulates HIV-1 replication and we
have recently extended this work by showing that m6A also enhances the replication and pathogenicity of
influenza A virus (IAV). A second epitranscriptomic modification, the isomerization of uridine to pseudouridine
(ψ), previously thought to be confined to non-coding RNAs, has recently been shown to be almost as prevalent
on cellular mRNAs as m6A and we have now observed that the genomic RNAs (gRNAs) packaged into virions
of the retrovirus murine leukemia virus display a range of epitranscriptomic modifications, including not only m6A
and ψ but also 5-methylcytosine (5mC) residues. In this grant application, we propose to use ultra-high
performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) to systematically identify and
quantitate the epitranscriptomic modifications that are present on highly purified gRNAs isolated from HIV-1
virions. We will then map the precise locations of three of the most prevalent epitranscriptomic modifications on
both the gRNA and on HIV-1 mRNAs expressed in CD4+ T-cells and myeloid cells. Next, we will seek to silently
mutate these modified sites in the context of an infectious HIV-1 provirus and determine whether, and how, these
modifications affect viral gene expression and replication. We will also seek to identify the cellular factors that
deposit these epitranscriptomic marks on HIV-1 transcripts and we will then test the effect of loss of expression,
or overexpression, of these factors on HIV-1 replication in CD4+ T cells. Finally, we will analyze the effect of
environmental stresses, such as heat shock and treatment with drugs of abuse, specifically nicotine and
morphine, on the level of epitranscriptomic modification of cellular and viral transcripts expressed in HIV-1
infected cells. In parallel, we will also determine whether these same treatments affect the level of expression of
the cellular factors that add or remove epitranscriptomic marks. Together, this research is designed to determine
how epitranscriptomic gene regulation modulates HIV-1 replication and begin to shed light on how environmental
factors, including drugs of abuse, can affect this process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
-
批准号:10158875
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2021
-
负责人:BRYAN R. CULLEN
-
依托单位:
Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
-
批准号:10369728
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2021
-
负责人:BRYAN R. CULLEN
-
依托单位:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
-
批准号:9894777
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2018
-
负责人:BRYAN R. CULLEN
-
依托单位:
Effect of m6A editing of RNA on influenza A virus replication
-
批准号:9296268
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2017
-
负责人:BRYAN R. CULLEN
-
依托单位:
Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases
-
批准号:9427958
-
项目类别:
-
资助金额:$74.17万
-
财政年份:2015
-
负责人:BRYAN R. CULLEN
-
依托单位:
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
-
批准号:9136078
-
项目类别:
-
资助金额:$17.29万
-
财政年份:2015
-
负责人:BRYAN R. CULLEN
-
依托单位:
Reconstitution of a protective antiviral RNAi response in somatic human cells
-
批准号:8849841
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2014
-
负责人:BRYAN R. CULLEN
-
依托单位:
Reconstitution of a protective antiviral RNAi response in somatic human cells
-
批准号:8762673
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2014
-
负责人:BRYAN R. CULLEN
-
依托单位:
Role and mechanism of action of gamma herpesvirus microRNAs
-
批准号:8293437
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:BRYAN R. CULLEN
-
依托单位:
HIV-1: microRNA interactions
-
批准号:8233429
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
HIV-1: microRNA interactions
-
批准号:8607525
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
HIV-1: microRNA interactions
-
批准号:8098065
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
Influenza virus small RNAs
-
批准号:7875178
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
Function of alpha herpesvirus microRNAs
-
批准号:8102465
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
HIV-1: microRNA interactions
-
批准号:8433467
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
Influenza virus small RNAs
-
批准号:8071188
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
Nucleic Acid Biology
-
批准号:8180876
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
Molecular Virology Core
-
批准号:7930104
-
项目类别:
-
资助金额:$21.84万
-
财政年份:2010
-
负责人:BRYAN R. CULLEN
-
依托单位:
MONKEY RHADINOVIRUS, A MONKEY MODEL FOR HUMAN HERPESVIRUS 8
-
批准号:7715503
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2008
-
负责人:BRYAN R. CULLEN
-
依托单位:
MONKEY RHADINOVIRUS, A MONKEY MODEL FOR HUMAN HERPESVIRUS 8
-
批准号:7562121
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2007
-
负责人:BRYAN R. CULLEN
-
依托单位:
海外基金